MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 525285 | Name: Indolapril hydrochloride

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Indolapril hydrochloride is a novel nonsulfhydryl angiotensin converting enzyme (ACE) inhibitor. The antihypertensive response to Indolapril hydrochloride (0.03-1.0 mg/kg p.o.) was found to correlate with inhibition of vascular tissue ACE.

Chemical Structure

Indolapril hydrochloride
Indolapril hydrochloride
CAS#80828-32-6 (HCl)

Theoretical Analysis

MedKoo Cat#: 525285

Name: Indolapril hydrochloride

CAS#: 80828-32-6 (HCl)

Chemical Formula: C24H35ClN2O5

Exact Mass: 0.0000

Molecular Weight: 467.00

Elemental Analysis: C, 61.73; H, 7.55; Cl, 7.59; N, 6.00; O, 17.13

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
80828-32-6 (HCl) 80828-34-8 (diacid) 80876-01-3 (free base)
Synonym
Indolapril hydrochloride; Indolapril HCl; CI 907; CI907; CI-907; REV 6000A(SS); Sch 31846 hydrochloride.
IUPAC/Chemical Name
(2S,3aS,7aS)-1-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)hexahydro-2-indolinecarboxylic acid, 1-ethyl ester, monohydrochloride
InChi Key
QNSWMJYOGMUVGO-PABIKWFMSA-N
InChi Code
InChI=1S/C24H34N2O5.ClH/c1-3-31-24(30)19(14-13-17-9-5-4-6-10-17)25-16(2)22(27)26-20-12-8-7-11-18(20)15-21(26)23(28)29;/h4-6,9-10,16,18-21,25H,3,7-8,11-15H2,1-2H3,(H,28,29);1H/t16-,18-,19-,20-,21-;/m0./s1
SMILES Code
O=C([C@H]1N(C([C@@H](N[C@@H](CCC2=CC=CC=C2)C(OCC)=O)C)=O)[C@@]3([H])CCCC[C@@]3([H])C1)O.[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 467.00 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Blankley CJ, Kaltenbronn JS, DeJohn DE, Werner A, Bennett LR, Bobowski G, Krolls U, Johnson DR, Pearlman WM, Hoefle ML, et al. Synthesis and structure-activity relationships of potent new angiotensin converting enzyme inhibitors containing saturated bicyclic amino acids. J Med Chem. 1987 Jun;30(6):992-8. PubMed PMID: 3035180. 2: La Rocca PT, Squibb RE, Powell ML, Szot RJ, Black HE, Schwartz E. Acute and subchronic toxicity of a nonsulfhydryl angiotensin-converting enzyme inhibitor. Toxicol Appl Pharmacol. 1986 Jan;82(1):104-11. PubMed PMID: 3003964. 3: Roark WH, Tinney FJ, Cohen D, Essenburg AD, Kaplan HR. Synthesis and biological activity of modified peptide inhibitors of angiotensin-converting enzyme. J Med Chem. 1985 Sep;28(9):1291-5. PubMed PMID: 2993618. 4: Brunner HR, Nussberger J, Waeber B. The present molecules of converting enzyme inhibitors. J Cardiovasc Pharmacol. 1985;7 Suppl 1:S2-11. Review. PubMed PMID: 2580170. 5: Ryan MJ, Boucher DM, Cohen DM, Olszewski BJ, Singer RM, Smith RD, Kaplan HR. Antihypertensive profile of the angiotensin-converting enzyme inhibitors CI-906 and CI-907. Fed Proc. 1984 Apr;43(5):1330-2. PubMed PMID: 6323224. 6: Kaplan HR, Cohen DM, Essenburg AD, Major TC, Mertz TE, Ryan MJ. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors. Fed Proc. 1984 Apr;43(5):1326-9. PubMed PMID: 6323223. 7: Ryan MJ, Boucher DM, Cohen DM, Essenburg AD, Major TC, Mertz TE, Olszewski BJ, Randolph AE, Singer RM, Kaplan HR. Antihypertensive effects of CI-907 (indolapril): a novel nonsulfhydryl angiotensin converting enzyme inhibitor. J Pharmacol Exp Ther. 1984 Feb;228(2):312-8. PubMed PMID: 6319675. 8: Baum T, Sybertz EJ, Watkins RW, Ahn HS, Nelson S, Eynon E, Vander Vliet G, Pula KK, Sabin C, Desiderio DM, Becker FT, Vemulapalli S. Antihypertensive activity of SCH 31846, a non-sulfhydryl angiotensin-converting enzyme inhibitor. J Cardiovasc Pharmacol. 1983 Jul-Aug;5(4):655-67. PubMed PMID: 6193365. 9: Sybertz EJ, Baum T, Ahn HS, Nelson S, Eynon E, Desiderio DM, Pula K, Becker F, Sabin C, Moran R, Vander Vliet G, Kastner B, Smith E. Angiotensin-converting enzyme inhibitory activity of SCH 31846, a new non-sulfhydryl inhibitor. J Cardiovasc Pharmacol. 1983 Jul-Aug;5(4):643-54. PubMed PMID: 6193364.